Your browser doesn't support javascript.
loading
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals.
Healy, Katie; Pin, Elisa; Chen, Puran; Söderdahl, Gunnar; Nowak, Piotr; Mielke, Stephan; Hansson, Lotta; Bergman, Peter; Smith, C I Edvard; Ljungman, Per; Valentini, Davide; Blennow, Ola; Österborg, Anders; Gabarrini, Giorgio; Al-Manei, Khaled; Alkharaan, Hassan; Sobkowiak, Michal Jacek; Yousef, Jamil; Mravinacova, Sara; Cuapio, Angelica; Xu, Xinling; Akber, Mira; Loré, Karin; Hellström, Cecilia; Muschiol, Sandra; Bogdanovic, Gordana; Buggert, Marcus; Ljunggren, Hans-Gustaf; Hober, Sophia; Nilsson, Peter; Aleman, Soo; Sällberg Chen, Margaret.
Afiliação
  • Healy K; Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Pin E; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.
  • Chen P; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Söderdahl G; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
  • Nowak P; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Mielke S; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Hansson L; Laboratory for Molecular Infection Medicine Sweden MIMS, Umeå University, Umeå, Sweden.
  • Bergman P; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Smith CIE; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.
  • Ljungman P; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Valentini D; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Blennow O; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Österborg A; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Gabarrini G; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Al-Manei K; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Alkharaan H; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Sobkowiak MJ; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.
  • Yousef J; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Mravinacova S; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.
  • Cuapio A; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Xu X; Department of Transplantation, Karolinska University Hospital, Stockholm, Sweden.
  • Akber M; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Loré K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Hellström C; Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Muschiol S; Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Bogdanovic G; Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Buggert M; College of Dentistry, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
  • Ljunggren HG; Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Hober S; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.
  • Nilsson P; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.
  • Aleman S; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Sällberg Chen M; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Med ; 3(2): 137-153.e3, 2022 Feb 11.
Article em En | MEDLINE | ID: mdl-35075450
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia